Purpose Milk proteins and/or their hydrolysates have been reported to have beneficial effects for improving postprandial glycaemia. Gastric emptying is a major determinant of postprandial glycaemia, yet limited studies have examined the effects of intact milk proteins compared to hydrolysates on gastric emptying. We investigated gastric emptying of a casein hydrolysate compared to intact casein. Methods Nine overweight and obese adults (mean ± SD age: 59.5 ± 6.5 years and BMI 28.4 ± 2.6 kg/m 2 ) were studied in a randomised crossover design. Gastric emptying was assessed by paracetamol absorption test, with HPLC-MS being used for determining paracetamol and its primary metabolites in plasma. Glucose, insulin and amino acid responses were also assessed. Results Linear mixed model analysis showed no effect of treatment [F (1, 55) = 2.1, P = 0.16] or treatment × time interactions [F (6, 54) = 1.5, P = 0.21] for paracetamol concentrations. In addition, there were no significant differences between the intact casein and hydrolysate for any of the gastric emptying outcome measures (Cmax, AUC 0-30min , AUC 0-60min ; AUC 0-240min ). However, insulin was increased in the early postprandial period (iAUC 0-15min, iAUC 0-30min; P < 0.05) and there was a treatment effect for glucose [F (1, 53) = 5.3, P = 0.03] following the casein hydrolysate compared to intact casein. No significant differences in amino acids were found between the two conditions. Conclusions Gastric emptying of a casein hydrolysate compared to intact casein does not differ. Mechanisms other than gastric emptying, for example the presence of a bioactive peptide sequence, may contribute to the glycaemic management effects of certain milk protein hydrolysates and warrant further investigation.
Introduction
Milk protein, has received recent interest as a dietary component that may aid in the prevention of type 2 diabetes, a chronic disease characterised by impaired insulin secretion and insulin resistance [1] . Both whey and casein, which constitute ∼ 20 and 80% of the total milk protein fraction respectively [2] , have been demonstrated to stimulate insulin secretion in a variety of populations including healthy, obese, pre-diabetic and type 2 diabetic individuals [3] [4] [5] [6] [7] [8] [9] [10] . In addition, both whey and casein have been shown to lower postprandial blood glucose levels [4, 5, 7, 9] . Increasing evidence further suggests that the composition and/or source of protein ingested and subsequent digestion and absorption pattern may have a significant impact on the postprandial metabolic response [11] [12] [13] [14] [15] . For example casein hydrolysates, compared to intact casein, show a greater postprandial insulin response [16, 17] . However, the exact mechanisms behind the effects of different milk proteins for glycaemic management remain to be fully explored [18] .
Gastric emptying has a fundamental role in the digestion of nutrients and is a major determinant of postprandial glycaemia [19] and gastric symptoms [20, 21] . Differences 
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in gastric emptying rate could, therefore, be one potential mechanism contributing to differential effects of milk protein in different forms on postprandial glycaemia. However, while there is some evidence of faster digestion and absorption kinetics of milk proteins in their hydrolysed compared to intact forms [17] , few studies have examined gastric emptying. Calbet and Holst performed a crossover study in six healthy males and found no differences in gastric emptying between intact whey and casein proteins and their respective hydrolysates [22] . However, effects on glucose and insulin were not reported. Others have similarly shown no difference in gastric emptying rate of a whey protein isolate compared to whey hydrolysate in healthy males [10] . These findings suggest the effects of milk protein hydrolysates on postprandial glycaemia may be independent of gastric emptying, yet further studies are clearly needed to establish this hypothesis further. Despite a number of studies examining gastric emptying of intact whey and casein [9, 13, 23, 24] , the influence of protein hydrolysis has received very little attention.
Given the increasing global prevalence of type 2 diabetes, a better understanding of the mechanisms contributing to alterations in postprandial glycaemia with milk proteins is essential to fully realise their potential health benefits in future. The objective of the present study was to compare gastric emptying and amino acid responses to a casein hydrolysate with responses to intact casein in overweight and obese adults.
Methods

Participants
Fourteen individuals expressed interest in the study, five withdrew before commencing the study and nine individuals [overweight and obese adults (6 male, 3 female)] commenced and completed both test days. Inclusion criteria were as follows: male or female; aged 40-65 years; BMI > 25 kg/ m 2 , no history or gastrointestinal disorder; non-diabetic; no medical conditions and not taking medication known to influence any of the outcome measures. The inclusion criteria regarding age and BMI were selected to represent a more at risk group for T2D, and are identical criteria to a series of studies being undertaken in our laboratory examining the effects of milk proteins for glycaemic management, therefore allowing comparison of results. The study was approved by the Human Research Ethics Committee at University College Dublin and written informed consent was obtained from each participant prior to participation in the study.
Design
Participants attended the laboratory on two separate test days one week apart, following a 12-h overnight fast, and having avoided alcohol and strenuous exercise for 24 h. On arrival at the laboratory, participants were fitted with a cannula and blood samples were collected in the fasting state into lithium heparin (for paracetamol and glucose) and serum (for insulin and amino acids) tubes. On each test day participants were provided with a fixed breakfast, consisting of two slices of white toasted bread, 40 g strawberry jam and 100 ml orange juice (macronutrient breakdown: 74 g carbohydrate, 2.1 g fat, 8.5 g protein).
In addition, participants consumed a 10% (w/v) solution (12 g protein dissolved in 120 ml mineral water (Ballygowan, Ireland)) of either (a) a novel casein hydrolysate or (b) a sodium caseinate (intact protein), in a randomised, crossover design. Participants consumed 1.5 g paracetamol with the protein solution as a marker of gastric emptying. Blood samples were subsequently collected at 15, 30, 60, 90, 120 and 240 min after ingestion of the test meal and protein drink. Blood samples were centrifuged at 770×g for 10 min at 4 °C and stored at − 80 °C until analysis.
Determination of paracetamol, paracetamol glucuronide and paracetamol sulfate in plasma
The paracetamol absorption test provides a detailed wellvalidated evaluation of gastric emptying [25, 26] . HPLC-MS was used for determining paracetamol in plasma in the present study, as it can detect concentrations lower than those detectable with commercially based assays [27] , and allows the possibility of quantifying the major metabolites. Several steps were taken to validate the LCMS laboratory methods used in the present study to detect paracetamol and its primary metabolites in plasma.
LCMS method validation
Stock solutions (containing paracetamol, paracetamol glucuronide and paracetamol sulfate) were prepared in methanol (HPLC grade, Sigma Aldrich, Steinheim, Germany), and samples at known concentrations were prepared in human plasma (drug-free), plus internal standards [Acetaminophend4 (APAP-d4) (Sigma Aldrich, Steinheim, Germany) and β-d-glucuronide-d3 (APAP-Glc-d3) (Toronto Research Chemicals Inc., Ontario, Canada)]. Intra-day variability of three replicate samples at each concentration, inter-day variability of three identical runs (> 7 days apart), accuracy, linearity and matrix effects were evaluated.
Sample analysis
Five-point calibration curves were obtained by fortifying drug-free human plasma with working solutions of paracetamol, paracetamol glucuronide and paracetamol sulfate as described above over the concentration range 0.24-18.20 µg/ ml for paracetamol, 0.52-39.28 µg/ml for paracetamol glucuronide and 0.37-27.75 µg/ml for paracetamol sulfate (equivalent to 1.6-120 µM for all). Calibration curves and a quality control sample prepared at known concentrations of 9.10, 19.64 and 13.87 µg/ml for paracetamol, paracetamol glucuronide and paracetamol sulfate, respectively (equivalent to 60 µM for all), were included in each run in duplicate. The study samples to be analysed were prepared by adding 100 µl of plasma sample, 200 µl methanol and 20 µl of internal standard. Samples were vortexed for 30 s and centrifuged at 16870×g for 10 min at room temperature. 200 µl of the supernatant was then transferred to a new tube and evaporated by Speed Vac at 30 °C for 60 min. The residue was re-constituted in a 100 µl 50:50 solution of water-methanol, vortexed for 30 s, centrifuged at 16870×g for 10 min at room temperature and analysed by LCMS.
LCMS conditions used for all analyses
A Thermoscientific Exactive Benchtop LC-MS system (Thermo Scientific, Waltham, USA) and a Capcell Pak MG II C 18 column (2.0 × 150 mm, 5 µm, Shisheido, Tokyo, Japan) were used for analyses. Following the work of An et al. [27] , the mobile phase consisted of 0.1% formic acid (Sigma Aldrich, Steinheim, Germany) in either 95% water (v/v, mobile phase A) or 95% acetonitrile (HPLC grade, Sigma Aldrich, Steinheim, Germany; v/v, mobile phase B). The gradient started with 100% A and increased linearly to 80% B from 0 to 8 min, after which the column was reequilibrated with 100% A, at a flow rate of 0.3 ml/min. The column was maintained at 35 °C. Analysis was performed separately once in positive ion mode (for determination of paracetamol) and once in negative ion mode (for determination of paracetamol glucuronide and sulfate). Data acquisition and peak area integration were performed using Xcalibur software. Peak area ratio was calculated for each sample in positive mode as the peak area ratio of paracetamol to the internal standard APAP-d4, and in negative mode as the peak area ratio of paracetamol glucuronide or sulfate to the internal standard APAP-Glc-d3 and used to calculate sample concentrations against the calibration curves by non-linearregression analysis.
Amino acid analysis
A Phenomenex EZ: faast kit for free amino acid analysis (Phenomenex, California, USA) was used to determine the concentration of amino acid (AA) in serum samples. The procedure was followed as stated in the manufacturers' protocol. In brief, the protocol consists of a solid phase extraction followed by a derivatisation and then a liquid/ liquid extraction. 100 µl of serum and 100 µl of internal standard were passed through a sorbent tip attached to a 1.5-mL syringe. The AA were bound to the sorbent tip and any impurities were passed into the syringe. The sorbent tip was then washed and injected into a vial for derivatisation using propyl chloroformate. 150 µl of the organic layer containing the AA was evaporated using N2. Samples were resuspended and analysed using an Agilent Technologies GC/MS system comprising an auto sampler 7683 series and a Gas Chromatography 7890A interfaced to a Mass Spectrometer 5975C (Agilent Technologies, California, USA).
Other biochemical measurements
Plasma glucose was analysed by Randox Daytona Clinical Chemistry Analyser (Randox, Crumlin, UK) (inter-assay: CV 0.6%) and insulin was assessed by ELISA (inter-assay CV: 5%) (Mercodia, Sweden).
Statistics
Shapiro-Wilk test was used to determine normality of the distribution of data. Paired t tests were used to compare outcome measures between treatments for normally distributed variables. Non-normally distributed data were log-transformed before statistical analysis. In addition, linear mixed model ANOVA was conducted with time, treatment and the interaction of time × treatment to assess effects of treatment, time × treatment interactions and subsequently including age and gender to examine the influence of age and gender. Area under the curve (AUC) and incremental AUC (iAUC; area above baseline) were calculated using the trapezoidal rule. Statistical analysis was performed using PASW Statistics version 24.0 (SPSS, Inc.) and Graph Pad Prism version 7.0 (GraphPad Software). Pearson correlations were performed to examine relationships between relevant variables. Significance was set at P < 0.05. Bonferroni correction was applied for t tests comparing amino acids to correct for multiple comparisons, with statistical significance set at P < 0.002.
Results
All participants completed the study. Participant characteristics were as follows: 6 males, 3 females, mean ± SD age: 59.5 ± 6.5 years and BMI 28.4 ± 2.6 kg/m 2 .
Method validation
The HPLC-MS methods were validated for quantification of paracetamol and its glucuronide and sulfate metabolites in human plasma over the expected concentration range. Coefficients of variation (CVs) for intra-run variability (n = 3 replicates) of paracetamol, paracetamol glucuronide and paracetamol sulfate were ≤ 10% at all concentrations, except for at the lowest concentration (1.6 µM) where the CV was ≤ 15% in all runs. CVs for inter-run variability for paracetamol peak area ratios were as follows: 0.24 µg/ml (1.6 µM): 9.9%, 0.60 µg/ml (4 µM) 4.6%, 1.21 µg/ml (8 µM): 9.3%, 9.1 ug/ml (60 µM): 4.0%, 18.2 µg/ml (120 µM): 7.8%. CVs for inter-run variability for paracetamol glucuronide peak area ratios were as follows: 0.52 µg/ml (1.6 µM): 9.5%, 1.31 µg/ ml (4 µM): 9.3%, 2.62 µg/ml (8 µM The accuracy of quality control samples was within 10% of the known concentration for both paracetamol and paracetamol glucuronide and within 15% of the known concentration for paracetamol sulfate for all runs. Matrix effects were < 5% comparing samples prepared in drug-free human plasma with solutions of controls.
Gastric emptying
Four-hour paracetamol concentration time profiles are shown in Fig. 1a . The inter-run CV for the quality control sample across all runs was 5%. Linear mixed model analysis showed an effect of time throughout the morning on paracetamol concentrations [F (6, (Table 1) . These data indicate no significant differences in gastric emptying between the casein hydrolysate and intact casein. However, there was large variability in the responses as evident in Table 1 and shown in supplementary Figure S1 .
Paracetamol glucuronide and sulfate
No significant differences were observed comparing the paracetamol glucuronide and sulfate responses to the hydrolysate versus intact protein (Table 1 ; Fig. 1b, c) , except for the AUC 0-240min for paracetamol glucuronide which was significantly increased following the hydrolysate (Table 1) . (Table 2 ). However, there was a trend towards a significant reduction in glucose iAUC 0-120min following the casein hydrolysate compared to the intact casein (Table 2) .
Insulin
Four-hour postprandial insulin time profiles are shown in Fig. 2 . Linear mixed model analysis revealed that there were no statistically significant treatment effects or differences between treatments for maximum concentration (C max ) (P > 0.05 for all). However, there was a significant time × treatment interaction [F (6, 47) = 4.1, P < 0.01] and a greater insulin iAUC 0-15min, and iAUC 0-30min , following the hydrolysate compared to the intact casein (Table 3) .
Amino acids
Four-hour postprandial amino acid profiles are shown in Fig. 3 . There were no significant differences in any of the amino acid responses to the casein hydrolysate versus intact casein, after adjusting for multiple comparisons (see supplementary Tables S1 and S2 ). There were trends towards an increased initial postprandial phenylalanine response (AUC 0-30min , P = 0.008; iAUC0-30 min, P = 0.009) and increased overall postprandial proline response (AUC 0-240min , P = 0.008; iAUC 0-240min , P = 0.008) following the hydrolysate compared to intact casein; however, this was not significant after adjusting for multiple comparisons. No significant correlations were observed between phenylalanine and proline and glucose or insulin responses (P > 0.05 for all).
Discussion
Although the digestion and absorption kinetics of milk proteins have been examined in a number of studies, few have compared gastric emptying of intact proteins with their hydrolysates. As casein proteins clot at a low pH, which can cause casein to aggregate into a gel in the stomach [11, 28, 29] , it could be hypothesised that hydrolysed casein may empty faster from the stomach, due to the 'pre-digestion' of the protein that occurs during the food processing hydrolysis process. However the present study demonstrates no difference in gastric emptying of a casein hydrolysate compared to intact casein in overweight and obese adults. In addition, no significant differences in amino acid responses were found, despite a significant increase in insulin secretion in the initial postprandial period following the casein hydrolysate.
The limited previous studies comparing gastric emptying of intact milk proteins with hydrolysates [10, 22] have nevertheless shown similar findings. Calbet and Holst observed no difference in the gastric emptying of a 600 ml solution (containing 60 g protein) of a casein or whey hydrolysate compared to their intact proteins in six healthy males, assessed using George's double sampling aspiration technique [22] . Power et al. similarly observed no difference in the gastric emptying of a 500 ml solution (containing 45 g protein) of a whey protein hydrolysate compared to intact whey isolate in 16 healthy males, assessed using the paracetamol absorption test [10] . In the present study, gastric emptying of the protein drink (120 ml solution containing 12 g protein) was assessed in overweight and obese individuals using the paracetamol absorption test. Taken together, these findings indicate no difference in gastric emptying of milk protein hydrolysates compared to intact proteins across different populations and methodologies. These findings suggest that mechanisms other than gastric emptying contribute to the effects of milk protein hydrolysates on glycaemic management. While paracetamol was the primary outcome measure for gastric emptying, we also studied the responses of the primary paracetamol metabolites. Paracetamol is metabolised in the liver primarily by conjugation to paracetamol glucuronide (55%) and paracetamol sulfate (30%) [30] . We observed a significantly greater overall paracetamol glucuronide (0-240 min) response to the hydrolysate compared to intact protein. To the best of our knowledge, only one study using the paracetamol absorption test to compare milk proteins and hydrolysates has reported on the primary metabolites. Stanstrup et al. [23] found a delay in paracetamol glucuronide and sulfate responses with intact whey protein compared to other protein sources including casein. In the present study, the differences in the 4-h paracetamol glucuronide response curve were particularly evident at 1-2 h postprandially. One potential explanation could be that the early insulin secretion in response to the hydrolysate may have stimulated glucose uptake and thus enhanced glucuronidation. Animal studies have shown hepatic glycogen to be reflected by paracetamol glucuronide concentrations [31] ; however, this warrants further investigation in humans.
In addition to gastric emptying, another mechanism whereby hydrolysates could exert effects on insulin secretion and glycaemic management may be the action of amino acids [16, 17] . However, we observed no significant differences in the amino acid response to the casein hydrolysate compared to intact casein in the present study, suggesting they were not a contributing mechanism to the effects on glucose and insulin observed. This is in contrast to previous findings of an enhanced amino acid availability and insulin secretion following hydrolysed casein compared to intact casein [17] . Others have shown an increased phenylalanine response following hydrolysed whey compared to intact whey protein, despite no significant differences in gastric emptying [10] . Although not significant in the present study, phenylalanine was the only amino acid to show a trend towards an increase in the initial postprandial period following the hydrolysate, and in the total 4-hour postprandial period, proline was the only amino acid to show a trend towards an increase following the hydrolysate. However, neither amino acid correlated with glucose or insulin responses, suggesting amino acids are unlikely the primary mechanism contributing to the effects on insulin and glucose we observed.
The presence of a bioactive peptide sequence either originally present in the hydrolysate or formed during gastrointestinal digestion [32] presents a further intriguing potential mechanism warranting future study. Bioactive peptides are defined as specific protein fragments that have a beneficial impact on body functions and may ultimately influence health [33] . Milk protein-derived peptides with a range of health functions have been described [34] . However, the structure and sequence of milk protein-derived peptides exerting bioactivity for glycaemic management has received little investigation in human studies. Interestingly, proline is a characteristic feature of β-casomorphins [35, 36] , and following casein ingestion, Boutrou et al. [37] noted that most of the peptides identified in the human jejunum contained at least two proline residues, consistent with evidence that proline containing peptides are resistant to degradation [6] . Therefore, although clearly speculative, it is possible that the trend towards an increased proline response that we observed in the present study could suggest proline may have formed part of a bioactive peptide sequence either originally present in the casein hydrolysate or formed during digestion. Future work is needed to characterize peptide sequences present in the GI tract and bloodstream after ingestion of the hydrolysate and to fully determine their functional significance in terms of glycaemic management.
Some methodological aspects of the current study should be considered. The present study focused on gastric emptying and amino acids as potential mechanistic explanations for the effects of the casein hydrolysate on postprandial glycaemia. Relatively small sample sizes are sufficient to detect clinically relevant changes in gastric emptying in overweight and obese individuals [38] , and the present study was powered to detect differences in the primary outcome measure. The paracetamol absorption test outcome measures have been shown to correlate well with gastric emptying using seven sampling time-points [25] as used in the present study. However, a greater sampling frequency may increase the accuracy of the results and better characterise the overall postprandial pattern of paracetamol and its metabolites and should be considered in future studies. It should also be noted that the participants in the present study were overweight and obese adults aged 40-65 years, with no known medical conditions. As such the findings cannot be extrapolated to other populations, although separate studies have shown similar findings in young healthy males [10, 22] . The age (40-65 years) and body mass index (> 25 kg/m 2 ) inclusion criteria for the present study were selected to represent a more at risk group for type 2 diabetes, and, therefore, one where milk proteins could potentially have a significant impact in glycaemic management and type 2 diabetes prevention.
In summary, understanding the mechanistic pathways involved is essential for the benefits of milk proteins for glycaemic management to be fully realised in future. Gastric emptying can account for as much as 40-50% of variations in postprandial glycaemia [19] and is, therefore, an important potential underlying mechanism to investigate. The current findings add to the literature by demonstrating that gastric emptying is not affected by milk protein hydrolysis. Other mechanisms contributing to the glycaemic management effects of milk protein hydrolysates, including the potential presence of bioactive peptides, warrant further investigation.
